United States was Mirum Pharmaceuticals’s largest region in fiscal 2025, bringing in $401.55M of $521.31M (77%).
| Geography | FY 2024 | FY 2025 |
|---|---|---|
| United States | $274.17M | $401.55M |
| Rest Of The World | $62.24M | $119.77M |
| Total | $336.41M | $521.31M |
Mirum Pharmaceuticals brought in $521.31M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 55.0% from $336.41M in fiscal 2024. United States was the largest at $401.55M (77.0%), ahead of Rest Of The World at $119.77M (23.0%).
Compared with fiscal 2024, Rest Of The World grew 92.4% to $119.77M and United States grew 46.5% to $401.55M.
Mirum Pharmaceuticals (MIRM) reports its revenue by geography. In fiscal 2025, United States was its largest region, bringing in $401.55M (77.0% of the total), followed by Rest Of The World at $119.77M (23.0%).
United States was Mirum Pharmaceuticals' largest region in fiscal 2025, bringing in $401.55M, or 77.0% of the $521.31M total across its two regions.
Rest Of The World grew faster than United States in fiscal 2025, up 92.4% from $62.24M to $119.77M. United States grew 46.5% to $401.55M.
Every figure comes from Mirum Pharmaceuticals' annual financial filings, as reported. Each line keeps the name Mirum Pharmaceuticals gives it, and years follow its fiscal calendar.
Mirum Pharmaceuticals' revenue by geography goes back to fiscal 2024, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.